Fan Z - Search Results

1

Recombinant human erythropoietin antagonizes trastuzumab treatment of breast cancer cells via Jak2-mediated Src activation and PTEN inactivation.

Liang K, Esteva FJ, Albarracin C, Stemke-Hale K, Lu Y, Bianchini G, Yang CY, Li Y, Li X, Chen CT, Mills GB, Hortobagyi GN, Mendelsohn J, Hung MC, Fan Z. Liang K, et al. Among authors: fan z. Cancer Cell. 2010 Nov 16;18(5):423-35. doi: 10.1016/j.ccr.2010.10.025. Cancer Cell. 2010. PMID: 21075308 Free PMC article.

2

Sensitization of breast cancer cells to radiation by trastuzumab.

Liang K, Lu Y, Jin W, Ang KK, Milas L, Fan Z. Liang K, et al. Among authors: fan z. Mol Cancer Ther. 2003 Nov;2(11):1113-20. Mol Cancer Ther. 2003. PMID: 14617784

3

Differential responses to doxorubicin-induced phosphorylation and activation of Akt in human breast cancer cells.

Li X, Lu Y, Liang K, Liu B, Fan Z. Li X, et al. Among authors: fan z. Breast Cancer Res. 2005;7(5):R589-97. doi: 10.1186/bcr1259. Epub 2005 May 24. Breast Cancer Res. 2005. PMID: 16168102 Free PMC article.

4

Epidermal growth factor receptor (EGFR) ubiquitination as a mechanism of acquired resistance escaping treatment by the anti-EGFR monoclonal antibody cetuximab.

Lu Y, Li X, Liang K, Luwor R, Siddik ZH, Mills GB, Mendelsohn J, Fan Z. Lu Y, et al. Among authors: fan z. Cancer Res. 2007 Sep 1;67(17):8240-7. doi: 10.1158/0008-5472.CAN-07-0589. Cancer Res. 2007. PMID: 17804738

5

Responses of cancer cells with wild-type or tyrosine kinase domain-mutated epidermal growth factor receptor (EGFR) to EGFR-targeted therapy are linked to downregulation of hypoxia-inducible factor-1alpha.

Lu Y, Liang K, Li X, Fan Z. Lu Y, et al. Among authors: fan z. Mol Cancer. 2007 Oct 11;6:63. doi: 10.1186/1476-4598-6-63. Mol Cancer. 2007. PMID: 17931419 Free PMC article.

6

Requirement of hypoxia-inducible factor-1alpha down-regulation in mediating the antitumor activity of the anti-epidermal growth factor receptor monoclonal antibody cetuximab.

Li X, Lu Y, Liang K, Pan T, Mendelsohn J, Fan Z. Li X, et al. Among authors: fan z. Mol Cancer Ther. 2008 May;7(5):1207-17. doi: 10.1158/1535-7163.MCT-07-2187. Mol Cancer Ther. 2008. PMID: 18483308

7

The epidermal growth factor receptor antibody cetuximab induces autophagy in cancer cells by downregulating HIF-1alpha and Bcl-2 and activating the beclin 1/hVps34 complex.

Li X, Fan Z. Li X, et al. Among authors: fan z. Cancer Res. 2010 Jul 15;70(14):5942-52. doi: 10.1158/0008-5472.CAN-10-0157. Cancer Res. 2010. PMID: 20634405 Free PMC article.

8

Roles of autophagy in cetuximab-mediated cancer therapy against EGFR.

Li X, Lu Y, Pan T, Fan Z. Li X, et al. Among authors: fan z. Autophagy. 2010 Nov;6(8):1066-77. doi: 10.4161/auto.6.8.13366. Autophagy. 2010. PMID: 20864811 Free PMC article.

9

Constitutively active Harvey Ras confers resistance to epidermal growth factor receptor-targeted therapy with cetuximab and gefitinib.

Luwor RB, Lu Y, Li X, Liang K, Fan Z. Luwor RB, et al. Among authors: fan z. Cancer Lett. 2011 Jul 1;306(1):85-91. doi: 10.1016/j.canlet.2011.02.035. Epub 2011 Mar 15. Cancer Lett. 2011. PMID: 21411223 Free PMC article.

10

The anti-EGFR antibody cetuximab sensitizes human head and neck squamous cell carcinoma cells to radiation in part through inhibiting radiation-induced upregulation of HIF-1α.

Lu H, Liang K, Lu Y, Fan Z. Lu H, et al. Among authors: fan z. Cancer Lett. 2012 Sep 1;322(1):78-85. doi: 10.1016/j.canlet.2012.02.012. Epub 2012 Feb 17. Cancer Lett. 2012. PMID: 22348829 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9,457 results

Search Page

Filters